Levosimendan in Acute Kidney Injury Study, a prospective, randomized, monocenter, double blind, placebo-controlled study to investigate the efficacy and safety of Levosimendan in Intensive Care Patients with Acute Kidney Injury.

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2014
This article has no abstract
Epistemonikos ID: 9a2467a45cd96043f31abdb51546d795a878728f
First added on: Jan 22, 2025